sb-Peptide

Executive Summary

sb-Peptide (formerly Smart-Bioscience) is a privately held French company headquartered in Bordeaux, specializing in custom peptide synthesis, analysis, and catalog products since its founding in 2003. With over a decade of industrial experience, the company offers a comprehensive range of services including complex peptide modifications, process development, and a proprietary 10-day express synthesis service. Serving a global clientele primarily in academic research and proteomics, sb-Peptide differentiates itself through rapid turnaround, technical expertise, and flexibility in handling demanding peptide requirements. Its longstanding presence and focus on quality make it a reliable partner in the competitive peptide synthesis market. The peptide synthesis market is driven by growing demand for customized peptides in drug discovery, diagnostics, and proteomics. sb-Peptide's established infrastructure and express service position it well to capture increasing outsourced synthesis needs. However, as a private company with no disclosed funding or valuation, its growth trajectory is opaque. The company may benefit from expanded automation or strategic partnerships, though near-term catalysts are not publicly known. Overall, sb-Peptide represents a steady, service-oriented business within the life science tools sector.

Upcoming Catalysts (preview)

• Q4 2026Launch of enhanced modification capabilities (e.g., cyclic or fluorescent peptides)60% success
• TBDMajor pharma contract for custom peptide supply30% success
• Q2 2027Expansion into proteomics kits or services40% success